Mark N Cruickshank
4PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 15, 2022
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.Laurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank
|Aug 30, 2022
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.Tomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo
|Jul 02, 2021
To Be, or Notch to Be: Mediating Cell Fate from Embryogenesis to Lymphopoiesis.Han Leng Ng, Elizabeth Quail, Mark N Cruickshank
|Aug 05, 2018
Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers.Edina Wang, Anabel Sorolla, Paula T Cunningham
Pageof 1
Frequent Collaborators
2 joint publications
Rishi S Kotecha
1 joint publications
Jonghwan Kim
1 joint publications
Tomoya Isobe
1 joint publications
Masatoshi Takagi
1 joint publications
Akira Nishimura
1 joint publications
Genta Nagae
1 joint publications
Yosuke Tanaka
1 joint publications
Shuhei Asada
1 joint publications
Reina Takeda
1 joint publications
Kenichi Yoshida
